5WK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aligos Therapeutics Inc

Watchlist Manager

Watchlist

Price: 10.725 EUR Market Closed

Market Cap: €837.7m

	Aligos Therapeutics Inc F:5WK	US
	Majestic Corporation PLC OTC:MCJCF	UK
	Copart Inc NASDAQ:CPRT	US
	Peach Property Group AG SIX:PEAN	CH
B	Brown & Brown Inc F:BTW	US

Profitability Summary

Aligos Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-4.025%

Negative 3Y Average Operating Margin

-1.764%

Declining Operating Margin

-586% > -4.025%

Negative Net Margin

-1.107%

Negative 3Y Average Net Margin

-1.469%

Declining Net Margin

-593% > -1.107%

Negative Free Cash Flow Margin

-3.794%

Negative 3Y Average Free Cash Flow Margin

-1.642%

Declining Free Cash Flow Margin

-582% > -3.794%

Negative ROE

-197%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-782%

Declining ROIC

-425% > -1.031%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.